Compound details
3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazole-5-carboxylic acid ethyl ester
| Compound ID | CDAMM00326 |
|---|---|
| Common name | 3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazole-5-carboxylic acid ethyl ester | IUPAC name | ethyl 3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazole-5-carboxylate |
| Molecular formula | C13H14N2O5 |
| Retention time | 58.1 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 279.095 | Theoretical mz | 279.098 |
| Error | 9.12 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.45 |
| Inchi key | UAOQPEANZVBDPV-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C(OCC)C1=NC(=NO1)C=2C=CC(OC)=C(OC)C2 |
| Superclass | Organoheterocyclic compounds |
| Class | Azoles |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9GZV3 | SLC5A7 | High-affinity choline transporter (by homology) | T83143 | SEA |
| P22303 | ACHE | Acetylcholinesterase | T30082 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SEA |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P04818 | TYMS | Thymidylate synthase (by homology) | T98397 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SEA |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SEA |
| Q14833 | GRM4 | Metabotropic glutamate receptor 4 | T99402 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SEA |
| P42338 | PIK3CB | PI3-kinase p110-beta subunit | T05031 | SEA |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SEA |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| P56524 | HDAC4 | Histone deacetylase 4 | T63816 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| P25440 | BRD2 | Bromodomain-containing protein 2 | T86597 | SEA |
| Q15059 | BRD3 | Bromodomain-containing protein 3 | T42048 | SEA |
| Q03181 | PPARD | Peroxisome proliferator-activated receptor delta | T36557 | SEA |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| P54760 | EPHB4 | Ephrin receptor | T49507 | SwissTargetPrediction |
| P25105 | PTAFR | Platelet activating factor receptor | T87023 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SEA |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction and SEA |
| O96017 | CHEK2 | Serine/threonine-protein kinase Chk2 | T28713 | SEA |
| P01375 | TNF | TNF-alpha | T20178 | SEA |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| Q9Y5Y9 | SCN10A | Sodium channel protein type X alpha subunit (by homology) | T43739 | SEA |
| O00329 | PIK3CD | PI3-kinase p110-delta subunit | T67849 | SEA |
| P51955 | NEK2 | Serine/threonine-protein kinase NEK2 | T49102 | SEA |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | T09538 | SwissTargetPrediction and SEA |
| P10721 | KIT | Stem cell growth factor receptor | T57700 | SEA |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction and SEA |
| P09211 | GSTP1 | Glutathione S-transferase Pi | T21669 | SEA |
| Q9Y251 | HPSE | Heparanase | T47623 | SEA |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SwissTargetPrediction |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SEA |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | T59102 | SEA |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | T44458 | SwissTargetPrediction |
| P16591 | FER | Tyrosine-protein kinase FER | T16993 | SEA |
| Q12908 | SLC10A2 | Ileal bile acid transporter | T24982 | SEA |
| P10619 | CTSA | Lysosomal protective protein | T37154 | SEA |
| Q02127 | DHODH | Dihydroorotate dehydrogenase | T61400 | SEA |
| P48736 | PIK3CG | PI3-kinase p110-gamma subunit | T95913 | SEA |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SEA |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SEA |
| P35398 | RORA | Nuclear receptor ROR-alpha | T43206 | SEA |
| P78527 | PRKDC | DNA-dependent protein kinase | T81735 | SEA |
| O14976 | GAK | Serine or threonine-protein kinase GAK | T00043 | SEA |
| Q9H228 | S1PR5 | Sphingosine 1-phosphate receptor Edg-8 | T50089 | SEA |
| P21453 | S1PR1 | Sphingosine 1-phosphate receptor Edg-1 | T13852 | SEA |
| P00749 | PLAU | Urokinase-type plasminogen activator | T17758 | SEA |
| P27815 | PDE4A | Phosphodiesterase 4A | T61744 | SEA |
| O75908 | SOAT2 | Acyl coenzyme A:cholesterol acyltransferase 2 | T14463 | SEA |
| P30536 | TSPO | Translocator protein (by homology) | T75440 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SEA |
| P08236 | GUSB | Beta-glucuronidase | T96413 | SEA |
| P16234 | PDGFRA | Platelet-derived growth factor receptor | T53524 | SEA |
| P00374 | DHFR | Dihydrofolate reductase | T17345 | SEA |
| O75582 | RPS6KA5 | Ribosomal protein S6 kinase alpha 5 | T50224 | SEA |
| Q9Y2T6 | GPR55 | G-protein coupled receptor 55 | T87670 | SEA |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SEA |
| P08631 | HCK | Tyrosine-protein kinase HCK | T31406 | SEA |
| O95819 | MAP4K4 | Mitogen-activated protein kinase kinase kinase kinase 4 | T71367 | SEA |
| P51451 | BLK | Tyrosine-protein kinase BLK | T74307 | SEA |
| Q9UBF8 | PI4KB | PI4-kinase beta subunit | T12541 | SEA |
| Q13936 | CACNA1C | Voltage-gated L-type calcium channel alpha-1C subunit | T51115 | SEA |
| P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | T64205 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| Q05513 | PRKCZ | Protein kinase C (PKC) | T59190 | SEA |
| Q9NRA0 | SPHK2 | Sphingosine kinase 2 | T31989 | SEA |
| Q08493 | PDE4C | Phosphodiesterase 4C | T12081 | SEA |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| Q99500 | S1PR3 | Sphingosine 1-phosphate receptor Edg-3 | T11241 | SEA |
| Q9Y256 | RCE1 | Prenyl protein specific protease | T10756 | SEA |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SEA |
| Q96SB4 | SRPK1 | Serine/threonine-protein kinase SRPK1 | T94201 | SEA |
| Q12851 | MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | T07191 | SEA |
| O95977 | S1PR4 | Sphingosine 1-phosphate receptor Edg-6 | T17523 | SEA |
| P22413 | ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | T63194 | SEA |
| Q9Y337 | KLK5 | Kallikrein 5 | T11808 | SEA |
| Q9H2X6 | HIPK2 | Homeodomain-interacting protein kinase 2 | T53952 | SEA |
| O43781 | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | T97149 | SEA |
| P22735 | TGM1 | Protein-glutamine gamma-glutamyltransferase K | T63217 | SEA |
| Q9H8M2 | BRD9 | Bromodomain-containing protein 9 | T46216 | SEA |
| P04156 | PRNP | Prion protein | T08722 | SEA |
| Q9P0G3 | KLK14 | Kallikrein-14 | T39195 | SEA |
| P49862 | KLK7 | Kallikrein-7 | T79155 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| Q9UBS0 | RPS6KB2 | Ribosomal protein S6 kinase beta-2 | T42760 | SEA |
| Q7RTX1 | TAS1R1 | Taste receptor | T41263 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| P47870 | GABRB2 | GABA(A) receptor beta-2 | T80387 | SEA |
| Q9NXA8 | SIRT5 | NAD-dependent deacetylase sirtuin-5 | T91940 | SEA |
| P10323 | ACR | Acrosin | T24595 | SEA |
| Q92560 | BAP1 | Ubiquitin carboxyl-terminal hydrolase BAP1 | T92628 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T98397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04818 | TYMS |
| T98397 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P04818 | TYMS |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T99402 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q14833 | GRM4 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T05031 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42338 | PIK3CB |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T63816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P56524 | HDAC4 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T86597 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P25440 | BRD2 |
| T42048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q15059 | BRD3 |
| T42048 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q15059 | BRD3 |
| T36557 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | Q03181 | PPARD |
| T36557 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q03181 | PPARD |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T49507 | DI0060 | Brain cancer | [ICD-11: 2A00] | P54760 | EPHB4 |
| T49507 | DI0111 | Cystic/dysplastic kidney disease | [ICD-11: GB8Y] | P54760 | EPHB4 |
| T49507 | DI0238 | Lung cancer | [ICD-11: 2C25] | P54760 | EPHB4 |
| T49507 | DI0261 | Metastatic meninges neoplasm | [ICD-11: 2D51] | P54760 | EPHB4 |
| T49507 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P54760 | EPHB4 |
| T87023 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P25105 | PTAFR |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T28713 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96017 | CHEK2 |
| T20178 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P01375 | TNF |
| T20178 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P01375 | TNF |
| T20178 | DI0351 | Psoriasis | [ICD-11: EA90] | P01375 | TNF |
| T20178 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P01375 | TNF |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T43739 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q9Y5Y9 | SCN10A |
| T43739 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | Q9Y5Y9 | SCN10A |
| T43739 | DI0374 | Sensation disturbance | [ICD-11: MB40] | Q9Y5Y9 | SCN10A |
| T43739 | DI0396 | Substance abuse | [ICD-11: 6C40] | Q9Y5Y9 | SCN10A |
| T67849 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | O00329 | PIK3CD |
| T67849 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00329 | PIK3CD |
| T67849 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | O00329 | PIK3CD |
| T67849 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O00329 | PIK3CD |
| T67849 | DI0395 | Stomach cancer | [ICD-11: 2B72] | O00329 | PIK3CD |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T09538 | DI0164 | Genetic prion disease | [ICD-11: 8E02] | P05186 | ALPL |
| T09538 | DI0330 | Parasitic infection | [ICD-11: 1D0Y-1G2Z] | P05186 | ALPL |
| T57700 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P10721 | KIT |
| T57700 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P10721 | KIT |
| T57700 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P10721 | KIT |
| T57700 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P10721 | KIT |
| T57700 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P10721 | KIT |
| T57700 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P10721 | KIT |
| T57700 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P10721 | KIT |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T21669 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P09211 | GSTP1 |
| T47623 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | Q9Y251 | HPSE |
| T47623 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q9Y251 | HPSE |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T59102 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P09619 | PDGFRB |
| T59102 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P09619 | PDGFRB |
| T59102 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09619 | PDGFRB |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T44458 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P50750 | CDK9 |
| T44458 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P50750 | CDK9 |
| T44458 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50750 | CDK9 |
| T44458 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P50750 | CDK9 |
| T44458 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P50750 | CDK9 |
| T44458 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P50750 | CDK9 |
| T44458 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50750 | CDK9 |
| T24982 | DI0349 | Pruritus | [ICD-11: EC90] | Q12908 | SLC10A2 |
| T37154 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P10619 | CTSA |
| T61400 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q02127 | DHODH |
| T61400 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q02127 | DHODH |
| T95913 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P48736 | PIK3CG |
| T95913 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48736 | PIK3CG |
| T95913 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48736 | PIK3CG |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T43206 | DI0235 | Liver cancer | [ICD-11: 2C12] | P35398 | RORA |
| T43206 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P35398 | RORA |
| T81735 | DI0360 | Rectum cancer | [ICD-11: 2B92] | P78527 | PRKDC |
| T81735 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P78527 | PRKDC |
| T00043 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O14976 | GAK |
| T50089 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q9H228 | S1PR5 |
| T13852 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P21453 | S1PR1 |
| T13852 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P21453 | S1PR1 |
| T17758 | DI0211 | Inherited coagulation factor deficiency | [ICD-11: 3B14] | P00749 | PLAU |
| T17758 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00749 | PLAU |
| T61744 | DI0037 | Asthma | [ICD-11: CA23] | P27815 | PDE4A |
| T14463 | DI0017 | Adrenal cancer | [ICD-11: 2D11] | O75908 | SOAT2 |
| T75440 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P30536 | TSPO |
| T75440 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30536 | TSPO |
| T75440 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P30536 | TSPO |
| T75440 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P30536 | TSPO |
| T75440 | DI0271 | Mood/affect symptom | [ICD-11: MB24] | P30536 | TSPO |
| T75440 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P30536 | TSPO |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T96413 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | P08236 | GUSB |
| T53524 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P16234 | PDGFRA |
| T53524 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P16234 | PDGFRA |
| T53524 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P16234 | PDGFRA |
| T17345 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P00374 | DHFR |
| T17345 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00374 | DHFR |
| T17345 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P00374 | DHFR |
| T17345 | DI0427 | Urinary tract infection | [ICD-11: GC08] | P00374 | DHFR |
| T87670 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q9Y2T6 | GPR55 |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T31406 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P08631 | HCK |
| T12541 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | Q9UBF8 | PI4KB |
| T12541 | DI0440 | Zoonotic viral disease | ICD-11: 1D6Y | Q9UBF8 | PI4KB |
| T51115 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q13936 | CACNA1C |
| T64205 | DI0383 | Skin and skin-structure infection | [ICD-11: 1F28-1G0Z] | P42224 | STAT1 |
| T59190 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q05513 | PRKCZ |
| T31989 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRA0 | SPHK2 |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T11241 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q99500 | S1PR3 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T94201 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q96SB4 | SRPK1 |
| T07191 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q12851 | MAP4K2 |
| T63194 | DI0350 | Pseudoxanthoma elasticum | ICD-11: EC40 | P22413 | ENPP1 |
| T63194 | DI0438 | Vitamin/non-protein cofactor absorption/transport disorder | ICD-11: 5C63 | P22413 | ENPP1 |
| T63217 | DI0045 | Autosomal Recessive Ichthyosis | [ICD-11: EC20] | P22735 | TGM1 |
| T46216 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q9H8M2 | BRD9 |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T42760 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9UBS0 | RPS6KB2 |
| T41263 | DI0078 | Cholera | [ICD-11: 1A00] | Q7RTX1 | TAS1R1 |
| T80387 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P47870 | GABRB2 |
| T80387 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P47870 | GABRB2 |
| T80387 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P47870 | GABRB2 |
| T80387 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P47870 | GABRB2 |